The General Assembly meeting will be held to a Canadian company to produce vaccines and veterinary medicines in 12/10/2013 to discuss the final accounts for the financial year ended 31/12/2012 and the capital increase from 4.500 billion to 5.400 billion (20%) in accordance with Article (55 / II) and Article (55 / III) and will be the last trading session on the company’s shares on 02/12/2013.
The meeting of the General Authority for a Canadian company to produce vaccines and veterinary medicines
- Post author:admin2540
- Post last modified:January 20, 2023
- Post comments:0 Comments